Rapid Micro Biosystems
RPID
42 hedge funds and large institutions have $27.7M invested in Rapid Micro Biosystems in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 14 closing their positions.
3.21% less ownership
Funds ownership: 70.45% → 67.24% (-3.2%)
14% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 14
21% less funds holding
Funds holding: 53 → 42 (-11)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
67% less capital invested
Capital invested by funds: $82.8M → $27.7M (-$55.1M)
71% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$2.43M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$391K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$168K |
| 4 |
GCM
Glenview Capital Management
New York
|
+$146K |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$52.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$3.42M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$1.1M |
| 3 |
AI
Arena Investors
Purchase,
New York
|
-$455K |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$164K |
| 5 |
TGA
TPG GP A
Fort Worth,
Texas
|
-$155K |
RPID Hedge Fund Activity: Q4 2022 in Review
42 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Rapid Micro Biosystems (RPID) for Q4 2022, worth a combined $27.7M — down 67% from $82.8M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of RPID and 4 opened new positions — a net loss of 10 holders — while 14 trimmed existing stakes and 12 added.
The largest buyer was Goldman Sachs, adding an estimated $2.43M. The largest seller was JP Morgan Chase, cutting an estimated $3.42M.
- 42 institutional investors held Rapid Micro Biosystems (RPID) as of Q4 2022, down from 53 in Q3 2022.
- Funds reported $27.7M of Rapid Micro Biosystems stock for Q4 2022, down 67% quarter-over-quarter.
- 4 funds opened new Rapid Micro Biosystems positions in Q4 2022 and 14 closed out, a net change of -10 holders.
- The largest Rapid Micro Biosystems buyer in Q4 2022 was Goldman Sachs, an estimated $2.43M added.
- The largest Rapid Micro Biosystems seller in Q4 2022 was JP Morgan Chase, an estimated $3.42M sold.
Based on aggregated 13F filings for Q4 2022.